A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
Page Count: 39
Table of Contents
Market Analysis: POC COVID-19 Testing
Overview of POC COVID-19 Testing
Market Outlook
Major Product Activity
Setting Market
Top Company Briefs
Abbott
Roche
Quidel
Becton Dickinson
Executive News Briefing
Pathware Appoints New CEO
Mainz Biomed Appoints New COO
Personalis Appoints New VP of Diagnostic Sales
Financial Highlights: bioMérieux, Guardant Health, Lucira Health
bioMérieux Full-Year Sales up 10.5% in 2021 Like-for-Like
Guardant Reports Growth in Clinical (+38.5%) and Biopharma (+16.5%) Test Volumes
Lucira Health Reports First Full Year of Commercialization
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Partnerships and Collaborations
Mergers and Acquisitions
Industry Watch
COVID-19 Update
Region Watch
Kenya
Saudi Arabia
Broad-based Company Announcements
Biomerica Submitted H. pylori Test to FDA
Bruker Launches New LiquidArray Multiplex PCR Assays
What is the Size of IVD Market Segments? Who’s Winning? Who’s Merged? Who’s Launched Game-Changing Products?
One book definitively answers these questions, from a publisher that is focused on in vitro diagnostics. Now in its 13th edition, this…